Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors

Journal of the American Animal Hospital Association

Volumn 40, Issue 2, 2004, Pages 124-130

  Davies, David R ^a   Wyatt, Kenneth M ^a   Jardine, John E ^b   Robertson, Ian D ^a   Irwin, Peter J ^a  

^a MURDOCH UNIVERSITY   (Australia)

^b Vetpath Laboratory Services   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; VINBLASTINE;

ARTICLE; CANCER ADJUVANT THERAPY; CAUSE OF DEATH; CONTROLLED STUDY; DIARRHEA; DOG DISEASE; FOLLOW UP; MASTOCYTOMA; MORTALITY; NEUTROPENIA; NONHUMAN; SEPSIS; SKIN TUMOR; TUMOR RECURRENCE; VOMITING;

CANIS FAMILIARIS;

EID: 18244400464     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0400124     Document Type: Article

References (33)

1. Finnie JW, Bostock DE. Skin neoplasia in dogs. Aust Vet J 1979;55:602-604.
2. Ladds PW, Kraft H, Sokale A, et al. Neoplasms of the skin of dogs in tropical Queensland. Aust Vet J 1983;60:87-88.
3. Rothwell TLW, Howlett CR, Middleton DJ, et al. Skin neoplasms of dogs in Sydney. Aust Vet J 1987;64:161-164.
4. Er JC, Sutton RH. A survey of skin neoplasms in dogs from the Brisbane region. Aust Vet J 1989;66:225-227.
5. Burrows AK. Skin tumors in the dog and cat - a west Australian perspective. In: Small animal oncology. Perth, Western Australia: Murdoch Univ Found Cont Vet Ed, 1991:69-74.
6. Brodey RS. Canine and feline neoplasia. Adv Vet Sci Comp Med 1970;14:309-354.
7. Bostock DE. Neoplasia of the skin and mammary glands in dogs and cats. In: Kirk RW, ed. Current Veterinary Therapy VI: Small Animal Practice. Philadelphia: WB Saunders, 1977:493-505.
8. Bostock DE. The prognosis following surgical removal of mastocytomas in dogs. J Small Anim Pract 1973;14:27-40.
9. Patnaik AK, Ehler WJ, MacEwen EG. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 1984;21:469-474.
10. Bostock DE, Crocker D, Harris K, et al. Nucleolar organizer regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumors. Br J Canc 1989;59:915-918.
11. Simoes JPC, Schoning P, Butine M. Prognosis of canine mast cell tumors: a comparison of three methods. Vet Pathol 1994;31:637-647.
12. Thamm DH, Vail DM. Mast cell tumors. In: Withrow SJ, MacEwen EG, eds. Small Animal Clinical Oncology. 3rd ed. Philadelphia: WB Saunders, 2001:261-282.
13. Al-Sarraf R, Mauldin GN, Patnaik AK, et al. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs. J Vet Intern Med 1996;10:376-378.
14. LaDue T, Price GS, Dodge R, et al. Radiation therapy for incompletely resected canine mast cell tumors. Vet Radiol and Ultrasound 1998;39:57-62.
15. Frimberger AE, Moore AS, LaRue SM, et al. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993). J Am Anim Hosp Assoc 1997;33:320-324.
16. McCaw DL, Miller MA, Bergman PJ, et al. Vincristine therapy for mast cell tumors in dogs. J Vet Intern Med 1997;11:375-378.
17. Gerritsen RJ, Teske E, Kraus JS, et al. Multi-agent chemotherapy for mast cell tumors in the dog. Vet Quart 1998;20:28-31.
18. Rassnick KM, Moore AS, Williams LE, et al. Treatment of canine mast cell tumors with CCNU (lomustine). J Vet Intern Med 1999;13:601-605.
19. Thamm DH, Mauldin EA, Vail DM. Prednisone and vinblastine chemotherapy for canine mast cell tumor - 41 cases (1992-1997). J Vet Intern Med 1999;13:491-497.
20. Turrel JM, Kitchell BE, Miller LM, et al. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. J Am Vet Med Assoc 1988;193:936-940.
21. Powers BE. The pathology of neoplasia. In: Withrow SJ, MacEwen EG, eds. Small Animal Clinical Oncology. 3rd ed. Philadelphia: WB Saunders, 2001:4-17.
22. Séguin B, Leibman NF, Bregazzi VS, et al. Clinical outcome of dogs with grade-II mast cell tumor treated with surgery alone: 55 cases (1996-1999). J Am Vet Med Assoc 2001;218:1120-1123.
23. Weisse C, Shofer FS, Sorenmo K. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. J Am Anim Hosp Assoc 2002;28:71-73.
24. Misdorp W. Incomplete surgery, local immunostimulation, and recurrence of some tumor types in dogs and cats. Vet Quart 1987;9:279-286.
25. Grier RL, Di Guardo G, Myers R, et al. Mast cell tumor destruction in dogs by hypotonic solution. J Small Anim Pract 1995;36:385-388.
26. Michels GM, Knapp DW, DeNicola DB, et al. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases. J Am Anim Hosp Assoc 2002;38:458-466.
27. McCaw DL, Miller MA, Ogilvie GK, et al. Response of canine mast cell tumors to treatment with oral prednisone. J Vet Intern Med 1994;8:406-408.
28. Ginn PE, Fox LE, Brower JC, et al. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors. Vet Pathol 2000;37:33-39.
29. Abadie JA, Amardeilh MA, Delverdier ME. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. J Am Vet Med Assoc 1999;215:1629-1634.
30. O'Keefe DA, Couto CG, Burke-Schwartz C, et al. Systemic mastocytosis in 16 dogs. J Vet Intern Med 1987;1:75-80.
31. McManus PM. Frequency and severity of mastocytaemia in dogs with and without mast cell tumors: 120 cases (1995-1997). J Am Vet Med Assoc 1999;215:355-357.
32. Bookbinder PF, Butt MT, Harvey HJ. Determination of the number of mast cells in lymph node, bone marrow, and buffy coat cytologic specimens from dogs. J Am Vet Med Assoc 1992;200:1648-1650.
33. Langenbach A, McManus PM, Hendrick MJ, et al. Sensitivity and specificity of methods for assessing the regional lymph nodes in dogs and cats with solid tumors. J Am Vet Med Assoc 2001;218:1424-1428.